Hold on ACN — position with structured triggers, not conviction overload
Hold on ACN with structured triggers. The debate resolves decisively to Hold, supported by three of four voices (research manager, trader, conservative, neutral) against a single aggressive analyst advocating upgrade to Buy. The valuation floor (12.25x forward P/E, 24.4% ROE, $12.6B FCF, net-cash balance sheet, $8.3B/yr capital return) provides hard support, while the 200 SMA at $205 remains the dividing line between confirmed uptrend and structural downtrend. Prior Underweight calls produced wrong-direction results but trim sizing (retained 80-85% core) preserved dividend carry—direct application of that lesson means no trim, just Hold with defined triggers. The aggressive analyst's mean-reversion math to $275 requires three stacked conditions unlikely in current environment (multiple re-rate from 14x to 22x, TTM earnings stable, AI narrative fully unwinds). The 30-45 day re-evaluation window aligns with Q4 FY26 bookings as the decisive catalyst. Tail risk: macro shock cuts multiple to 10x → $135-140 zone, but bounded by valuation floor and capital return machine.
| Position | Action |
|---|---|
| Current exposure | Maintain position size; do not add on rally into $205 resistance, do not trim aggressively given valuation floor |
| Weekly close above $205 on volume (>5M sustained 5+ sessions) | Upgrade to Overweight; re-engage with full position |
| Weekly close below $152 on volume | Downgrade to Underweight; hard exit/trimming trigger |
| Overweight accounts seeking hedge | Collar: buy 6-month $155-160 puts, sell $230+ calls to monetize elevated IV |
ACN is at a multi-year low valuation while printing record earnings — this is a dislocation, not a value trap, and the AI integration thesis is driving, not threatening, its deal flow.
| Indicator | Value | Signal |
|---|---|---|
| RSI | 70.45 | neutral |
| MACD | 8.55 | bullish |
| MACD Signal | 5.98 | bullish |
| MACD Histogram | +2.57 | bullish |
| close_10_ema | 170.29 | bullish |
| close_50_sma | 152.56 | bullish |
| close_200_sma | 205.19 | bearish |
| Bollinger Upper Band | 188.34 | bullish |
| Bollinger Middle Band | 158.48 | bullish |
| Bollinger Lower Band | 128.62 | neutral |
| ATR | 7.99 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Weekly close below $152 on volume
Then: Downgrade to Underweight
↩ rebuts: “Bear's YTD -32.4% return argument”
EV: +53% (based on 5-year mean PE of ~$275 vs current ~$179.82; +14% to 200 SMA at $205 as near-term resistance) · concedes: Stock is below the 200 SMA at 205 — a lagging indicator concern worth monitoring; YTD return of -32.4% — real price pain investors have experienced; Weak bookings — a legitimate yellow flag, though not yet showing in margins or FCF; RSI at 70.45 — near overbought territory; Wide options-implied volatility — creates premium selling opportunity but also signals uncertainty
ACN at $180 is a value trap where the market is correctly pricing in structural AI displacement risk, decelerating revenue growth, and a technical setup that defines a bear-market bounce top—not a new bull trend.
EV: -$117 (-35% drawdown to retest lows) · concedes: Yes, there was a tactical rally; Yes, Cramer called it out; Yes, ACN is up 28% in 30 days; A daily close above 205 would be bullish
→ vs conservative: Conservative inverts the AI ROI logic — Accenture's own research showing C-suite AI confidence fading means MORE consulting work, not less, as companies hire Accenture to fix failed AI implementations
→ vs conservative: Record revenue, record EPS, and all-time high net income contradict the 'structural concern' framing — growth is decelerating from a strong base, which is normal mean reversion, not secular decline
→ vs conservative: The 'soft bookings' argument misses that ACN is actively printing enterprise wins (UniCredit, Coles, Dabur, New Look) while down 32% YTD — operational reality far outpaces market pricing
→ vs neutral: Patience has a real cost — waiting for 'more confirmation' at 12.25× forward earnings means missing multi-quarter re-ratings; confirmation comes after the move, not before, and by then you're chasing the breakout
| neutral |
| VWMA | 162.13 | bullish |
| Price | 179.82 | neutral |
Support: 170.29 · 158.48 · 152.56 · 128.62 · 116.75 | Resistance: 180.2 · 188.34 · 205.19
ACN shows a strong short-term bullish reversal with price +5.6% above the 10 EMA and +17.9% above the 50 SMA, while RSI at 70.45 approaches overbought and MACD confirms accelerating bullish momentum with histogram widening to +2.57. The stock is riding the upper Bollinger Band (188.34) with ATR elevated at 7.99, suggesting elevated volatility requiring wider stop-losses of $16-$20. Volume confirmation is healthy with VWMA at 162.13 rising steadily from ~$128 in mid-July, indicating institutional accumulation. Long-term trend remains bearish as price is -12.4% below the 200 SMA (205.19), which has capped price for months and defines the dominant structural downtrend.
Market Cap
$110.04 B
TTM Revenue
$73.10 B
TTM EPS
$12.51
Forward EPS
$14.68
PE (TTM)
14.37×
Forward PE
12.25×
PEG
1.30
Price / Book
3.45×
Dividend Yield
3.66%
Beta
1.074
52-Week High
$291.09
52-Week Low
$118.15
50-Day MA
$153.65
200-Day MA
$208.93
FY25 Revenue
$69.67 B
FY25 Gross Profit
$22.24 B
FY25 Operating Income
$10.84 B
FY25 Operating Margin
15.6%
FY25 Net Income
$7.68 B
FY25 Net Margin
11.0%
FY25 Diluted EPS
$12.15
TTM Net Income
$7.79 B
TTM EBITDA
$12.94 B
Gross Margin (TTM)
32.0%
Operating Margin (TTM)
16.96%
Net Margin (TTM)
10.66%
ROE (TTM)
24.41%
ROA (TTM)
10.90%
FCF Margin (TTM)
~17%
TTM Free Cash Flow
~$12.6 B
FCF Yield
~11.5%
FY25 Free Cash Flow
$10.87 B
FY25 Operating Cash Flow
$11.47 B
FY25 CapEx
($0.60 B)
FY25 Buybacks
$4.62 B
FY25 Dividends
$3.70 B
FY25 Total Capital Return
$8.32 B
Cash & Equivalents
$10.17 B
Total Debt
$8.39 B
Net Debt
-$1.78 B (net cash)
Goodwill
$25.32 B
Stockholders' Equity
$31.89 B
Current Ratio
1.34×
Revenue CAGR (FY22–FY25)
4.2%
Net Income CAGR (FY22–FY25)
3.7%
EPS CAGR (FY22–FY25)
4.3%
FY25 Revenue Growth
+7.4%
FY25 EPS Growth
+6.2%
FY23 Revenue Growth
+4.1%
FY24 Revenue Growth
+1.2%
Strengths
Concerns
Accenture's fundamentals are unambiguously strong with record TTM earnings ($7.79B net income, $12.51 EPS), revenue re-acceleration to +7.4% in FY25, and best-in-class profitability metrics (24.41% ROE, 16.96% operating margin). The stock has corrected ~40% from its $291 high to near its $118 52-week low despite improving fundamentals, resulting in a TTM PE of just 14.37× and FCF yield of ~11.5% — historically cheap levels. With a net-cash balance sheet, $8.3B+ in annual capital returns, and the stock trading closer to its 52-week low than high, the central thesis is whether the market's AI-disruption fears are overblown given that bookings and revenue are actually re-accelerating, not decelerating.
Macro: Fed on hold with 86% probability of no cuts in 2026; soft-landing base case (8% U.S. recession probability); S&P 500 favored as best 2026 performer (66%); oil-driven inflation risk from US-Iran deal uncertainty; risk-off tilt with Bitcoin below $64,000; resilient U.S. consumer spending providing modest support.